Elixinol Wellness Elevates Natalie Butler to CEO, Taps Adam Dimitropoulos as CFO

Leadership Transition at Elixinol Wellness

Elixinol Wellness Limited (ASX, EXL), a prominent player in the global hemp and wellness industry, has announced significant changes to its executive leadership team. Natalie Butler, previously an Executive Director with an expanded role since 2024, has been appointed Chief Executive Officer effective immediately. This move formalises her leadership during a period of transition and positions her to steer the company’s next growth phase.

Butler’s appointment comes with continuity, as she remains on the board and retains her existing remuneration arrangements. Her decade-long experience in scaling wellness and consumer brands, combined with her intimate knowledge of Elixinol’s operations, is expected to provide strategic clarity and executional discipline.

Financial Leadership and Strategic Focus

Alongside Butler’s elevation, Elixinol has appointed Adam Dimitropoulos as Chief Financial Officer, succeeding Josephine Lorenz who is stepping down after more than seven years with the company. Dimitropoulos brings a wealth of financial expertise, with over 25 years in senior roles across pharmaceuticals, health, biotech, and fast-moving consumer goods sectors globally.

His background in profit and loss enhancement, mergers and acquisitions, and operational transformation; including cost optimisation and working capital improvements; aligns with Elixinol’s stated focus on delivering sustained profitability. The Board expressed gratitude to Lorenz for her contributions during a transformative period for the company.

Strategic Implications and Market Positioning

Elixinol operates a vertically integrated business model in Australia, spanning human nutrition, wellness, pet wellness, and superfood ingredients, with a portfolio of well-known brands. The leadership changes underscore the company’s commitment to strengthening its governance and operational capabilities as it navigates competitive pressures and growth opportunities in the wellness sector.

Chairman Dave Fenlon highlighted the Board’s confidence in Butler’s leadership and Dimitropoulos’s financial acumen to execute strategic priorities. These appointments may also signal a readiness to pursue further operational efficiencies and possibly explore new avenues for expansion or capital deployment.

Investors will be watching closely to see how this refreshed leadership team translates strategy into tangible results in upcoming financial reports and market performance.